Form: 8-K

Current report filing

October 25, 2012


SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT


PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934


Date of Report (Date of earliest event reported): October 25, 2012


VolitionRX Limited

(Exact name of Company as specified in its charter)


Delaware

000-30402

91-1949078

(State or other jurisdiction

(Commission File Number)

(IRS Employer

Identification Number)

of Incorporation)

 

 


1 Scotts Road,

#24-05 Shaw Centre, Singapore, 228208  

(Address of principal executive offices)


Telephone:  (201) 618-1750

Facsimile:  +65 6333 7235

(Registrant’s Facsimile Number)


150 Orchard Road

Orchard Plaza 08-02

Singapore 238841

(Registrant’s Former Address,

if changed since last report)

 



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions:

 

      . Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 


      . Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 


      . Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


      . Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))





VOLITIONRX LIMITED

FORM 8-K

CURRENT REPORT


ITEM 8.01

OTHER EVENTS


On October 25, 2012, VolitionRX Limited, a Delaware corporation (the “Company”) relocated its principal executive offices from 150 Orchard Road, Orchard Plaza 08-02, Singapore 238841 to 1 Scotts Road, #24-05 Shaw Centre, Singapore, 228208.





SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



  

VolitionRX Limited  

 

 

 

Date: October 25, 2012 

/s/ Cameron Reynolds             

 

  

By:  Cameron Reynolds

 

Its:  Chief Executive Officer and President

 

 




2